Boehringer Ingelheim Pharma GmbH & Co KG, Department of Non-Clinical Drug Safety, Birkendorfer Str. 65 D-88397 Biberach/Ri?, Germany, Fax: +49-7351-542183, Email: ulrich.deschl@bc.boehringer-ingelheim.com
Ulrich Mohr
Cultex Laboratories GmbH, Hannover Medical Park, Feodor-Lynen-Stra?e 21, 30625 Hannover, Germany, Fax: +49 (0)511-563586-69, Email: u.mohr@cultex-laboratories.com
Editorial Office:
Helga Gressmann
Cultex-Laboratories GmbH, Hannover Medical Park, Feodor-Lynen-Stra?e 21, 30625 Hannover, Germany, Tel: +49 (0)511-563586-0, Fax: +49 (0)511-563586-69, Email: ExpToxicPathol@cultex-laboratories.com
Editorial Board:
Michaela Aufderheide
Cultex-Laboratories GmbH, Hannover, Germany
Wilfried Bartsch
Hamburg, Germany
Gary A. Boorman
Research Triangle Park, NC, USA
Daniel Costa
US Environmental Protection Agency, Research Triangle Park, NC, USA
Clemens Dasenbrock
Boehringer Ingelheim Pharma GmbH & Co KG, Department of Non-Clinical Drug Safety, Biberach, Germany
Daniel Dietrich
Konstanz, Germany
Kunio Doi
Tokyo, Japan
Makoto Enomoto
Nishichiyoda, Shizuoka, Japan H. Ernst, Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany
Heinrich Ernst
Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany
Victor J. Feron
TNO, Business Unit Toxicology and Applied Pharmacology, Zeist, The Netherlands